# First Light Biosciences Inc.: Form D filings

First Light Biosciences Inc., a biotechnology company in Bedford, MA, filed 4 Form D notices with the SEC between 2015 and 2018. The latest, on August 6, 2018, reports $3 million sold of a $5.9 million offering to 2 investors.

Find out what First Light Biosciences Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20First%20Light%20Biosciences%20Inc.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=First%20Light%20Biosciences%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Ffirst-light-biosciences-inc-1652991)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20First%20Light%20Biosciences%20Inc.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=First%20Light%20Biosciences%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Ffirst-light-biosciences-inc-1652991)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Massachusetts](https://specstream.ai/data/form-d/state/massachusetts): 1,533 rows, by operating companies, filed since November 1, 2024, $76.65, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/massachusetts
- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: ONE OAK PARK DRIVE, 2ND FLOOR, Bedford, MA, 01730
- Phone: (781) 271-0122
- Industry: Biotechnology
- Entity type: Corporation
- Incorporated in: Delaware
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1652991

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Aug 6, 2018 | New notice | $5,900,000 | $3,000,000 | $2,900,000 | 2 | Jul 30, 2018 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1652991/000165299118000001/0001652991-18-000001-index.htm) |
| Jan 24, 2017 | Amendment | $1,800,000 | $1,792,895 | $7,105 | 37 | Jul 29, 2016 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1652991/000165299117000001/0001652991-17-000001-index.htm) |
| Aug 3, 2016 | New notice | $1,500,000 | $811,175 | $688,825 | 21 | Jul 29, 2016 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1652991/000165299116000002/0001652991-16-000002-index.htm) |
| Sep 14, 2015 | New notice | $3,810,068 | $2,868,055 | $942,013 | 26 | Aug 28, 2015 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1652991/000165299115000001/0001652991-15-000001-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| William Moffitt | Director |  |
| Salvatore Salamone | Director |  |
| Donald Straus | Executive Officer, Director |  |
| Tripp Peake | Director |  |
| Thierry Bernard | Director |  |

## Other biotechnology companies in Massachusetts that filed recently

- [Zai Lab Ltd](https://specstream.ai/data/form-d/company/zai-lab-ltd-1704292) $249.9 million · Nov 9, 2026
- [AI3 Bio, Inc.](https://specstream.ai/data/form-d/company/ai3-bio-inc-2019875) offering · Nov 4, 2026
- [Tru Singular Health, Inc.](https://specstream.ai/data/form-d/company/tru-singular-health-inc-2158834) $1 million · Oct 30, 2026
- [511 Therapeutics, Inc.](https://specstream.ai/data/form-d/company/511-therapeutics-inc-1946264) $500,000 · Oct 30, 2026
- [Elucid Bioimaging Inc.](https://specstream.ai/data/form-d/company/elucid-bioimaging-inc-1585931) $56.2 million · Oct 27, 2026
- [OrthoIQ, Inc.](https://specstream.ai/data/form-d/company/orthoiq-inc-2154488) $1.1 million · Oct 23, 2026
- [LeanBio Therapeutics, Inc.](https://specstream.ai/data/form-d/company/leanbio-therapeutics-inc-2160802) offering · Oct 22, 2026
- [Quiver Holdings Inc.](https://specstream.ai/data/form-d/company/quiver-holdings-inc-2160800) $3 million · Oct 21, 2026
- [Axelyf, Inc.](https://specstream.ai/data/form-d/company/axelyf-inc-2078406) $2.6 million · Oct 13, 2026
- [BIOVENTRIX, INC.](https://specstream.ai/data/form-d/company/bioventrix-inc-1283259) $1.2 million · Oct 8, 2026
- [Opus KSD, Inc.](https://specstream.ai/data/form-d/company/opus-ksd-inc-1668934) $680,801 · Oct 1, 2026
- [Xact Bio, Inc.](https://specstream.ai/data/form-d/company/xact-bio-inc-2157427) $10 million · Sep 28, 2026
- [Way Biosolutions, Inc.](https://specstream.ai/data/form-d/company/way-biosolutions-inc-2155613) $2 million · Sep 25, 2026
- [AutoIVF, Inc.](https://specstream.ai/data/form-d/company/autoivf-inc-1807161) $1.5 million · Sep 25, 2026
- [Typewriter Therapeutics, Inc.](https://specstream.ai/data/form-d/company/typewriter-therapeutics-inc-2156390) $56.3 million · Sep 21, 2026

[Every Form D from the week of Aug 6, 2018](https://specstream.ai/data/form-d/week/2018-08-06) · [All recent filings in Massachusetts](https://specstream.ai/data/form-d/state/massachusetts) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what First Light Biosciences Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).